ArticleGastroenterology research and practice2022

Outcomes of Pediatric Patients with Crohn's Disease Received Infliximab or Exclusive Enteral Nutrition during Induction Remission.

Yao Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.